Medical device manufacturers are continually looking to market new innovative products in multiple locations as quickly and as effectively as possible. As the industry continues to rapidly expand, health economic and outcomes research teams are searching for novel strategies to address the delays they face in product commercialization and reimbursement. While a globally harmonized system remains a work in progress, manufacturers are striving to set a single pathway for obtaining reimbursement for their new and existing product offerings.

Brief overview of Russian healthcare infrastructure and related government initiatives